Shares of Oxford Immunotec Global PLC (NASDAQ:OXFD) have been given an average rating of “Hold” by the seven analysts that are presently covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, one has assigned a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $18.75.
Several equities research analysts recently commented on OXFD shares. BTIG Research set a $21.00 price objective on Oxford Immunotec Global and gave the company a “buy” rating in a research report on Monday, December 18th. BidaskClub cut Oxford Immunotec Global from a “hold” rating to a “sell” rating in a research report on Saturday, December 9th. Piper Jaffray Companies dropped their price objective on Oxford Immunotec Global from $26.00 to $19.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 31st. Zacks Investment Research downgraded Oxford Immunotec Global from a “hold” rating to a “sell” rating in a report on Saturday, November 4th. Finally, Robert W. Baird reissued a “buy” rating and issued a $20.00 target price on shares of Oxford Immunotec Global in a report on Wednesday, November 1st.
In other Oxford Immunotec Global news, Director Richard A. Sandberg sold 3,000 shares of the stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $12.01, for a total value of $36,030.00. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 8.11% of the stock is currently owned by corporate insiders.
Shares of Oxford Immunotec Global (OXFD) opened at $11.91 on Monday. The company has a current ratio of 4.72, a quick ratio of 4.30 and a debt-to-equity ratio of 0.38. Oxford Immunotec Global has a 12-month low of $10.00 and a 12-month high of $19.51. The company has a market capitalization of $305.55, a price-to-earnings ratio of -5.90 and a beta of -0.30.
COPYRIGHT VIOLATION WARNING: This report was originally published by Community Financial News and is the property of of Community Financial News. If you are reading this report on another site, it was illegally copied and republished in violation of international copyright and trademark legislation. The correct version of this report can be read at https://www.com-unik.info/2018/02/19/oxford-immunotec-global-plc-oxfd-receives-average-recommendation-of-hold-from-brokerages.html.
Oxford Immunotec Global Company Profile
Oxford Immunotec Global PLC is a diagnostics company. The Company is focused on developing and commercializing tests for under-served immune-regulated conditions. The Company’s product lines and development activities principally focus on four areas: infectious diseases, transplantation, autoimmune and inflammatory disease and immune-oncology.
Receive News & Ratings for Oxford Immunotec Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Immunotec Global and related companies with MarketBeat.com's FREE daily email newsletter.